“dQ&A provides that independent voice to the diabetes discussion and goes out of their way to capture key market segments like Type 1’s, insulin users and pumpers.”
Suggested Articles
Patients Weathering Chaos but Seeing Results When Starting Mounjaro, According to Proprietary dQ&A® First Look Research
Mounjaro is a once weekly injectable medicine approved for adults with type 2 diabetes to be used along with diet and exercise to improve blood sugar…
Time in Range Outcomes from Six European Countries
Our European research…
Eight dQ&A® Abstracts Presented at ATTD 2023
We are excited to announce that…